Tenon Medical (TNON) Net Income towards Common Stockholders (2021 - 2026)

Tenon Medical has reported Net Income towards Common Stockholders for 6 years, with the latest figure at -$4.2 million in Q2 2026.

• On a quarterly basis, Net Income towards Common Stockholders fell 47.22% year-over-year to -$4.2 million in Q2 2026; TTM through Jun 2026 was -$13.9 million, a 7.72% decrease from a year earlier, with the FY2025 full-year figure at -$12.8 million, up 7.3% from the prior year.
• Net Income towards Common Stockholders was -$4.2 million for Q2 2026 at Tenon Medical, down from -$3.5 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was -$2.4 million in Q1 2022, with the low at -$7.9 million in Q4 2022.
• Average Net Income towards Common Stockholders over 5 years is -$3.8 million, with a median of -$3.4 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders plunged 1076.5% in 2022, then soared 60.13% in 2023.
• Over 5 years, Net Income towards Common Stockholders stood at -$7.9 million in 2022, then jumped by 60.13% to -$3.2 million in 2023, then decreased by 0.47% to -$3.2 million in 2024, then advanced by 9.68% to -$2.9 million in 2025, then tumbled by 46.76% to -$4.2 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$4.2 million (Q2 2026), -$3.5 million (Q1 2026), and -$2.9 million (Q4 2025), per Business Quant data.